Grzegorz S. Nowakowski

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

John P. Leonard, Marek Trněný, Koji Izutsu et al. · Journal of Clinical Oncology · 2019 · 421 citations · Full text

Medicine, Immunology, Oncology +15

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Wei Ding, Betsy LaPlant, Timothy G. Call et al. · Blood · 2017 · 412 citations · Full text

Medicine, Clinical Sciences, Oncology +6

Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon et al. · Journal of Clinical Oncology · 2014 · 364 citations · Full text

Medicine, Hematology, Oncology +16

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

Brian K. Link, Matthew J. Maurer, Grzegorz S. Nowakowski et al. · Journal of Clinical Oncology · 2013 · 332 citations · Full text

Medicine, Hematology, Oncology +14

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

Grzegorz S. Nowakowski, Annalisa Chiappella, Randy D. Gascoyne et al. · Journal of Clinical Oncology · 2021 · 270 citations · Full text

Medicine, Hematology, Oncology +15